DG-GT e.V.

In light of recent events and the development of this platform, continued activity is not conform with the values and objectives of #DGGTeV We are ending all activities on X. Find us here instead: DGGZT.bsky.social linkedin.com/in/dg-gt/ facebook.com/DGGTeV/

TODAY: Dont miss the last chance to submit your abstracts for the #annual #DGGTeV meeting 2025 in Dresden "From Lab to Life: Genome editing towards therapies" in coop. with @SaxoCell @tudresden_de Abstract submission: dg-gt.de/event-abstracts Programme: dg-gt.de/event-programme

Reminder for all #DGGTeV #members: The general assembly of the #DGGTeV is taking place ONLINE at 14:00 UTC+1 TODAY You should have recieved your access link in the mail Lets shape the future of #GeneTherapy and our #Society See you soon! #GeneTherapy #Germany #AnnualMeeting

The 2. #DGGTeV #Academy on #Virotherapy and #Oncolytic #Viruses in Heidelberg @DKFZ was a great success for our new #earlycareer format: It focused on #projectfeedback and #careeradvice from experts like H Büning @MHH_life, D Nettelbeck @NCT_HD and more! dg-gt.de/programmeacade…

Congratulations! The #DGGTeV proudly awards J.T Wagner et al. at @UniFAU one of the #PaperoftheQuarter #Awards #Q3_2024 for their work on a proof-of-concept for AAV vector-based delivery of protective antibodies during immunesuppression. more here: dg-gt.de/paper-of-the-q…

Election Notification 📢 The #DGGTeV is inviting all members to vote in the board election! Every registered memeber recieved an invitation to vote by mail 📩 Make sure to cast your vote until Dec. 10th to make the society fit for the next steps into the future of #genetherapy

Another #DGGTeV #Paperofthequarter #Award #Q3_2024 is presented to Constanca Figueiredo et al. @mhh_life for their work to promote immunosuppresion-free graft survival in porcine lung transplants via antigen knock-down mhh.de/itt/team/blasc… more here: dg-gt.de/paper-of-the-q…

Congratulations! The #DGGTev is delighted to award M.B. Demircan and L.J. Zinser @PEI_Germany with the #PaperoftheQuarter #Award #Q32024 for their development of DART-AAVs for in-vivo targeting of CD8 T cells. #PoQ #GeneTherapy details: dg-gt.de/paper-of-the-q…

The #DGGTeV is delighted to award Lei Lei @Uniklinik_Fr @UniFreiburg the second #esgct2024 travel grant. Don't miss her talk OR057 "Cell-type and time resolved genotoxicity of base editing" Thursday 24th at 10:00am #GeneTherapy #DGGTeV #Awards

Congratulations to Angela E. Araujo @MHH_life for the first of the #DGGTeV #esgct2024 travel grants. Make sure to join her talk ORO42 on the "Development of AAV variants to target T lymphocytes in vivo" today Oct. 23rd at 18:15

As part of our #mission the #DGGTeV grants young researchers #ecr with outstanding achievements the opportunity to present their work internationally via travel grants. This year we are delighted to support Angela Enrica Araujo @MHH_life and Lei Lei @Uniklinik_Fr at #esgct2024

We are at the #esgct2024 in #rome. Come visit us at our booth for a chat, sweet #haribo and all the information you need regarding membership and our upcoming events as the #DGGTeV #academy or #esgct #springschool more: dg-gt.de/currentacademy

After our Accessibility Webinar , we hope to see you on 13 November at 2 pm (CET) to learn how to better engage healthcare professionals and advocate for better care, diagnosis and support for the rare diseases community. To register, follow the link: us02web.zoom.us/webinar/regist…

It was super fun to join @EricTopol on his podcast Ground Truths and chat about genome design beyond CRISPR, DNA foundation models, AI agents for science, the @arcinstitute model, and more!

We would like to congratulate Giorgio Matronola, the winner of our Science Writing competition 2024 📝🏆 and runners-up Leona Bere and Syd McLean. We invite you to read their amazing articles on our blog 👇🏻 bsgct.org/bsgct-blogs

Exciting event news! The #DGGTeV is hosting the 2nd #Academy - present your work - get detailed feedback - connect with peers and experts This time we are at the @DKFZ in #Heidelberg focusing on #virotherapy and #oncolyticviruses REGISTRATION OPEN NOW: dg-gt.de/currentacademy

#geneTherapy #Pointer for everyone interested in virology within #DGGTeV to the upcoming GFV Meeting Details here: dg-gt.de/post/deutschen…

Are you wrapping up your PhD in the coming month, or are you currently a postdoc? Looking to dive deeper into cutting-edge research in cancer genomics, AI, and computational biology? Our lab (boevalab.inf.ethz.ch) is seeking passionate, ambitious researchers to join us through the SNSF Swiss Postdoctoral Fellowship program! 🧬✨ This fellowship offers a unique chance to collaborate in a dynamic lab focused on leveraging multi-omics and AI methods to advance our understanding of cancer biology. 🔹 Who Should Apply: Candidates with a strong background in computational biology and computer science, and who are enthusiastic about interdisciplinary research and innovation. 🔹 Why Join Us: Our lab provides a stimulating environment, support for growth, and the resources to develop your research expertise. Find more information about the application requirements and deadlines here: snf.ch/en/m1NtWp4nTEL… To contact our lab and indicate your interest, please, fill out this form before October 20: forms.gle/gRtQHomXAQJ8DU… We will contact you for an interview if your application satisfies the requirements.

#SaveTheDate for the #DGGTeV #GeneralAssembly ! The #DGGTeV is looking forward to host its members to discuss recent and future activities of the society and current developments - including the result presentation of the upcoming elections 2pm-3pm Thursday 12.12.2024 (Virtual)

Quarterly Reminder: If you have a great recent #geneTherapy #publication don't miss the #DGGTeV #paperoftheQuarter #PoQ #Award #2024Q3 Deadline for submission is next Thursday 10.10.24 Submission and eligibility here: #comp-kwvxbqyp" target="_blank" rel="nofollow noopener">dg-gt.de/paper-of-the-q…